Informazione tecnica HSE / 25 ° anno
/ Documenti disponibili:
44.307
/ Documenti scaricati: 31.903.923
/ Documenti scaricati: 31.903.923
Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
21754 | Update 05.03.2025
L'elenco delle sostanze e dei fornitori (persone interessate) pertinen...
Il Dipartimento dell'Ispettorato centrale della tutela della qualità e repressione frodi dei prodotti agroalimentari ...
26 Giugno 2017
Organizzato dal Ministero della Salute e Sapienza Università di Roma, in collaborazione con il M...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024